Wednesday, February 10, 2010, 12:56PM AEST - The Australian Stockmarket closes in 3 hours and 9 minutes.
To create a watchlist or portfolio of shares, Register

BioCryst Pharmaceuticals, Inc. (BCRX)

8:00AM AEST: 6.25 USD  Down 0.30 (4.58%)  
 MORE ON BCRX 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 BioCryst Pharmaceuticals, Inc. (NGM:BCRX) Delayed quote dataEdit
Last Trade:6.25 USD
Trade Time: 8:00AM AEST
Change:Down 0.30 (4.58%)
Prev Close:6.55
Open:6.66
Bid:5.56 x 100
Ask:N/A
1y Target Est:15.00
Day's Range:6.21 - 6.71
52wk Range:1.15 - 13.47
Volume:1,006,382
Avg Vol (3m):1,730,510
Market Cap:242.64M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add BCRX to Portfolio   Download Data

 HEADLINES 
Traders Send Select Stem Cell Shares Soaring
Indie Research (Tue 2:28AM)
New Star Analyst Rankings for BioCryst Pharmaceuticals, Inc.
StarMine (Sun, Feb 7)
Big Pharma's Shot In The Arm
at CNBC (Sat, Feb 6)
BioCryst Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
at Seeking Alpha (Fri, Feb 5)
BioCryst 4Q profit rises on flu drug sales
AP (Fri, Feb 5)
Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4
Indie Research (Fri, Feb 5)
BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Fri, Feb 5)
UPDATE - BioCryst Q4 results top Street on flu drug sales
at Reuters (Fri, Feb 5)
Q4 2009 BioCryst Pharmaceuticals Earnings Release - Time Not Supplied
CCBN (Thu, Feb 4)
BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update
PR Newswire (Thu, Feb 4)
More Headlines for BCRX...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.78
EPS Est (in 2 years) (Dec-10) :0.02
Avg Rec (current)*:2.8
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices